Paradigm Medical Industries, Inc.
Hier denke ias wir noch dieses Jahr 5-10 Cent sehen werden.
mfg
S.H.
die Zeit der Geschenke scheint vorbei zu sein...
schade eigentlich...
naja...wenigstens habe ich nochmal welche zu 0,006 bekommen...
mir ist es mittlerweile egal...
entweder ein Lächeln im Gesicht...irgendwann...
oder ein Totalverlust der sich aber in Grenzen hält...
ich bin ein Spieler...und liebe zocken...
einen Verlust von 0,7 Mil USD gemacht haben...
naja...wird wohl was dran sein bei dem Kursverlauf...
ich bleibe trotzdem dabei...gibt ja nicht mehr viel zu verlieren...
und meinetwegen können Sie auch erst 2007 anziehen, dann bin ich wenigstens steuerfrei... :-)
Paradigm Medical Enters into Exclusive Discussions with Leading Chinese Engineering Firm for Development and Production of Ultrasound and Medical Products
SALT LAKE CITY--(BUSINESS WIRE)--June 5, 2006--
Paradigm Medical Industries, Inc. (OTCBB: PMED.OB/PMEDW.OB), a leading innovative producer of ultrasound devices for the ophthalmic and medical industries, today announced it has entered into exclusive discussions with a leading Chinese medical engineering and research firm aimed at developing Paradigm's next generation of ultrasound products for the medical industry. Terms were not disclosed.
"We believe a potential collaboration with the Chinese firm's engineers and medical academicians will result in increased functionality and state-of-the-art ultrasound devices," said Paradigm Medical's President and Chief Executive Officer, Raymond Cannefax. "The Chinese firm and Paradigm Medical would jointly provide hardware and software engineering input based on the latest technological developments in order to develop products that will meet the needs of medical professionals using these ultrasound devices."
In addition to broadening its ophthalmic product line, the Company is expanding some of its ultrasound products into the veterinary industry. "There is a continual increase in veterinary ophthalmology, and we believe we can share in the growth and further enhance that market opportunity," Mr. Cannefax added.
"The Chinese firm's engineering, research, and production skills should also help dramatically in reducing our research and engineering expenditures. Our revitalized global sales and marketing organization is making significant efforts to enable the Company to maximize this opportunity," Mr. Cannefax added.
Paradigm Medical and the Chinese firm's executives will be meeting during the week of the 21st Congress of the Asian Pacific Academy of Ophthalmology (APAO) meeting, held this June in Singapore. New engineering concepts will be implemented into a newly designed 50 MHz specific Ultrasound BioMicroscope (UBM). Glaucoma and refractive ophthalmic experts attending APAO Congress will be able to provide valuable input to confirm the results are in line with their expectations.
Paradigm Medical Industries, Inc. (Salt Lake City, UT), currently develops, manufactures and markets high-tech, proprietary diagnostic equipment and consumable products for the medical industry. The Company is a leading developer of Ultrasound devices, and has been dubbed "The UBM Company" (Ultrasound BioMicroscope). Contact us at 801- 977-8970 or visit us at www.paradigm-medical.com.
This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.
Source: Paradigm Medical Industries, Inc.
Und es geht steil bergauf heute in USA bei hohen Umsätzen. Ich hoffe ihr seid noch alle dabei.
Gruss
S.H.
Monday June 19, 1:04 pm ET
SALT LAKE CITY--(BUSINESS WIRE)--June 19, 2006--Paradigm Medical Industries, Inc. (OTCBB: PMED.OB/PMEDW.OB), a leading innovative producer of ultrasound devices for the ophthalmic and medical industries, today announced it has signed a definitive agreement with MEDA Co. Ltd. (Tianjin) to jointly engineer and develop Paradigm\'s next generation of ultrasound and other medical products. MEDA is one of China\'s leading developers and producers of ultrasound devices.
ADVERTISEMENT
"We are pleased to be working with MEDA. Their engineering, research, and production capabilities are among the best in the world," said Paradigm Medical\'s President and Chief Executive Officer, Raymond Cannefax. "MEDA has already begun producing products for us to our specifications."
Mr. Cannefax added, "Initial ultrasound products have been received from MEDA and Paradigm has made initial sales of these devices in Europe. We expect all of our distributors worldwide to be carrying these products by mid-2006. After receiving U.S. and European regulatory approval in 2005 for our third generation Ultrasound BioMicroscope (UBM)--the P60--we are now working with MEDA on the next generation UBM as well as other proprietary new products and enhancement of our current devices.
"Paradigm Medical is presently the only company that manufactures and sells more than one UBM," Mr. Cannefax noted. "Upon completion of this new UBM project, the Company will offer four Ultrasound BioMicroscopes for medical and research sciences applications."
Paradigm Medical expects to be manufacturing its products at both its facility in Salt Lake City and in Tianjin. "We expect to have a series of new, collaborative products on display at the AAO Convention later this year," Mr. Cannefax concluded.
Paradigm Medical Industries, Inc. (Salt Lake City, UT), currently develops, manufactures and markets high-tech, proprietary diagnostic equipment and consumable products for the medical industry. The Company is a leading developer of Ultrasound devices, and has been dubbed "The UBM Company" (Ultrasound BioMicroscope). Contact us at 801-977-8970 or visit us at www.paradigm-medical.com.
This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.
Contact:
Paradigm Medical Industries, Inc.
Raymond Cannefax, 801-977-8970
19-Jun-2006
Entry into a Material Definitive Agreement, Financial Statements
ITEM 1.01 Entry into Worldwide OEM Agreement with MEDA Co., Ltd.
On June 12, 2006, Paradigm Medical Industries, Inc. (the "Company" entered into a Worldwide OEM Agreement (the "Agreement" with MEDA Co., Ltd. ("MEDA", one of China\'s leading developers and producers of ultrasound devices. Under the terms of the Agreement, MEDA agrees to jointly engineer, develop and manufacture the Company\'s next generation of the Ultrasound BioMicroscope, as well as other proprietary new products and enhancement of our current products. The products to be manufactured by MEDA, at agreed upon costs, and supplied to the Company for resale include the following new products: an Ultrasound BioMicroscope, two Ultrasound A/B Scans, a Biometric A-Scan and a pachymeter.
The Agreement provides that the Company and MEDA agree to jointly develop and collaborate in the improvement and enhancement of the Company\'s products and, in the interest of product development, enhancement and differentiation, MEDA agrees to give consideration to potential software development or enhancements made available to the Company for its products. Moreover, in the interest of product improvement, MEDA agrees to collaborate with the Company and its designated engineers, employees and consultants to consider and potentially implement jointly or individually the development of product enhancements on the Company\'s products to be manufactured by MEDA.
The software and hardware modifications designed jointly by the Company and MEDA will be considered the joint intellectual property of the Company and MEDA and may be used, without restriction, unless otherwise previously agreed to, by either party. MEDA also agrees to provide a 12 month warranty on all products that it manufactures for the Company. If defects cannot be corrected at the Company\'s facilities, the products may be returned to MEDA for the purposes of carrying out such repairs as required, and MEDA agrees to return the repaired products to the Company or its designated agent or distributor within ten working days from the date of receiving such products, at no cost to the Company, and MEDA will pay return freight costs.
MEDA further agrees to endeavor to answer any technical inquiries concerning the products it has manufactured. MEDA also agrees to train the Company\'s technical service engineers and designated international distributors as soon as possible after the signing of this Agreement, and as future needs arise and as MEDA can reasonably fit such training into the regular schedules of its employees. MEDA agrees to determine the need for future training on new products as necessary and will offer such training in Tiangin, China. For training conducted outside China, the Company or its designated distributors and/or service centers will be responsible for the traveling, living and hotel expenses for MEDA\'s engineers. Training is at no charge to the Company. The training will also be made available to the Company\'s designated repair agencies in order to provide service and repair on a worldwide basis. Such agencies will be considered authorized repair facilities for the products manufactured by MEDA.
The Agreement shall be effective for three years from date of execution. At the end of the three year term, representatives of the Company and MEDA will confer to determine whether to extend the term of the Agreement. This will have a practical effect of extending the term of the Agreement for an additional 120 days. If mutual agreement for extending the term of the Agreement is not reached within 120 days after the end of the three year term, then the Agreement will be deemed terminated. However, if within the 120 day period, the Company and MEDA mutually agree to extend the term of the Agreement, then thereafter either party may terminate the Agreement by providing 12 months prior written notice to the other party. All outstanding orders at the time of notification will be supplied under the terms of the Agreement, and MEDA will continue to fulfill all orders from the Company until the 12 month notice period has expired.
ITEM 9.01 Financial Statements and Exhibits
(c) Exhibits
10.1 Worldwide OEM Agreement with MEDA Co., Ltd.
100% drin sein...
nur meine Meinung...wie sehen das denn die anderen Investierten?
Fasst ihr auch wieder neuen Mut? ;-)
nette Geste... ;-))
Schlußkurs USA: 0,007 USD also 0,0056 €...